Public Meeting: Using Methods from PFDD Guidance 1 and Guidance 2

On June 30, 2022, FDA hosted a public meeting titled “Using Methods from PFDD Guidance 1 and Guidance 2 as Tools for Including Patient Experience Data in Clinical Trials: Who to Ask and How to Ask.” This meeting was the first in a series of two public meetings. Speakers and participants discussed a range of issues and best practices related to collecting patient input, selecting data collection methods, and developing sampling plans and strategies. External stakeholders presented examples of how they have used the guidance documents as tool to inform their collection of patient data.

You may find a link to the referenced guidance documents here: https://go.usa.gov/xJzDc
For more information, visit the meeting webpage: https://go.usa.gov/xJzDx
Be the first to comment